Week In Review: Innovent’s Hong Kong IPO: Raising $422 Million At $2 Billion Valuation

Innovent Biologics of Suzhou plans to raise $422 million in its Hong Kong IPO at a $2 billion valuation, according to multiple media reports (see story). The company, formed in 2011, struck a major $1 …
( read original story …)


Related Post

Mega project for 9,500 private flats in Hong Kong’...
views 10
Town planning authorities have given the final app...
Analysts upbeat about China’s equity market ...
views 13
Ricky Choi Wing-hung, a senior economist from Bank...
Reciprocal deal between Hong Kong and mainland Chi...
views 16
Hong Kong and mainland China signed a reciprocal d...
Scammers swindle Hong Kong man out of HK$430,000 i...
views 18
A 48-year-old man has become the biggest victim of...
Hong Kong set to adopt Open Banking
views 21
Hong Kong is set to be one of the first countries ...
A Look At Hong Kong Finance Investment Holding Gro...
views 24
Building up an investment case requires looking at...
From Vancouver to Hong Kong and back again: why so...
views 17
Some British Columbians who moved to Hong Kong for...
Hong Kong Business hails the most exceptional ente...
views 23
HONG KONG, Jan. 18, 2019 /PRNewswire/ -- On its 15...
Hong Kong light show proving a hit with residents ...
views 19
A photogenic light show illuminating the heart of ...
Hong Kong Bourse May Reverse Thursday’s Loss...
views 21
BOC Hong Kong dropped 1.01 percent, Sands China sh...